GeneFab Announces Two Presentations at the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting 2024
ALAMEDA, Calif., April 22, 2024 (GLOBE NEWSWIRE) -- GeneFab, LLC (“GeneFab”), an expert contract research, development and manufacturing organization (CRDMO) today announced two poster presentations at the upcoming American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting, which will be held May 7 to 11, 2024 in Baltimore, MD.
- ALAMEDA, Calif., April 22, 2024 (GLOBE NEWSWIRE) -- GeneFab, LLC (“GeneFab”), an expert contract research, development and manufacturing organization (CRDMO) today announced two poster presentations at the upcoming American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting, which will be held May 7 to 11, 2024 in Baltimore, MD.
- GeneFab employs expert genetic design and manufacturing methods to meet Advanced Therapy companies' needs.
- With a 92,000 square foot cGMP manufacturing facility in Alameda, California that supports various customer projects, including allogeneic cell therapy, CAR-T and synthetic biology research services.
- GeneFab’s presentations highlight two new technologies for control of payload production from cell therapies.